Medical Developments International (ASX:MVP) share price on watch after trading update

The Medical Developments International Ltd (ASX:MVP) share price will be one to watch on Friday after the release of a trading update…

| More on:
ASX share price on watch represented by surprised man with binoculars

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Friday following the release of an update after the market close.

What did Medical Developments International announce?

This afternoon Medical Developments International provided an update in relation to its Penthrox European Union (EU) transition activities and current trading conditions.

In respect to the former, the transition arrangements for taking back the distribution rights from Mundipharma in the EU are progressing to plan.

According to the release, progress to date includes the establishment of an EU based legal and corporate structure, contracting of pharmacovigilance and regulatory related service providers, and securing operational infrastructure in-market. The latter includes importation and logistics capability.

In addition, the marketing authorisations previously held by Mundipharma are being transferred concurrently to allow the company to assume control of sales and distribution activities on 1 March 2021.

The company's CEO, Brent MacGregor, commented: "The opportunity in the EU remains strong and we're revisiting our execution strategy, assessing and building on the foundation work done by Mundipharma, including determining where we can deploy a direct or hybrid selling model which brings enhanced control and margin. Europe will be the primary focus of MVP over the coming year."

Trading update.

The first half has been softer for Medical Developments International due to COVID-19 headwinds.

Management notes that following an early COVID pandemic surge in sales, the mild cold and flu season, along with improved community hygiene practices, has depressed demand for respiratory products.

Furthermore, reduced community activity is resulting in fewer ambulance movements and lower demand for Penthrox, which is better known as the green whistle.

Finally, Penthrox Australia sales have been impacted by timing differences associated with the transition from the exiting distribution partner, Mundipharma Australia.

However, overall reported revenue is showing growth. This is the result of accelerated milestone income amortisation from the hand-back of the EU distribution rights from Mundipharma.

Mr MacGregor concluded: "We are looking past these challenges. We expect to see a recovery in Australian sales in the coming months and will build infrastructure for the global growth of Penthrox. The transition arrangements in the EU are progressing well and additional rollouts into unlaunched markets will occur in 2021."

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough start to the week this Monday.

Read more »

Crude oil barrels rocketing.
ETFs

Why did the BetaShares Crude Oil ETF just spike 4%?

This ETF is attracting buyers in today's seller's market.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BWP, Metcash, Resolute Mining, and SHAPE shares are pushing higher today

These shares are starting the week on a positive note. But why?

Read more »

Workers at the port joyfully jump high in the air with shipping containers in the background.
Industrials Shares

$10,000 invested in Austal shares a year ago is now worth…

Austal is an Australian shipbuilding company founded in 1988 that builds ships for the US Navy.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to a disappointing week for investors this Friday.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Betr, Centuria Capital, GR Engineering, and Mach7 shares are pushing higher

These shares are having a good finish to the week. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX gave up an afternoon lead to close lower today.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising today

These shares are pushing higher on Thursday. But why?

Read more »